GPN Vaccines closed a $10 million private placement to fund manufacturing, testing expansion and regulatory preparation for Gamma-PN's Phase 2 development.
- Amount
- $10M
- Stage
- Private placement
- Announced
- 2 November 2026
- Use of funds
- Phase 2 preparations: cGMP batch manufacturing, OPA testing laboratory expansion, and IND submission to FDA.
- Checked
- Announced by the company